Literature DB >> 9596006

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease.

H Checkoway1, G M Franklin, P Costa-Mallen, T Smith-Weller, J Dilley, P D Swanson, L G Costa.   

Abstract

In a population-based case-control study, we found a reversal of the association of cigarette smoking with Parkinson's disease (PD) in relation to the monoamine oxidase B intron 13 genetic polymorphism. A reduced PD risk related to pack-years of smoking was detected for persons with the G allele, whereas an opposite effect was found among persons with the A allele. These results indicate an unexplained interaction between cigarette smoking and this genetic polymorphism.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9596006     DOI： 10.1212/wnl.50.5.1458

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

Review 3.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease.

Authors:  A H Evans; A D Lawrence; J Potts; L MacGregor; R Katzenschlager; K Shaw; J Zijlmans; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 5.  Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.

Authors:  Nick Marotta; Soojin Kim; Dimitri Krainc
Journal:  Expert Opin Drug Discov       Date:  2020-01-03       Impact factor: 6.098

6.  Environmental-genetic interactions in the pathogenesis of Parkinson's disease.

Authors:  Yoshio Tsuboi
Journal:  Exp Neurobiol       Date:  2012-09-17       Impact factor: 3.261

7.  Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2011-07-25       Impact factor: 2.474

8.  The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis.

Authors:  Ying Liu; Zhiyun Wang; Benshu Zhang
Journal:  Ann Saudi Med       Date:  2014 Jan-Feb       Impact factor: 1.526

9.  Genome-wide and candidate gene association study of cigarette smoking behaviors.

Authors:  Neil Caporaso; Fangyi Gu; Nilanjan Chatterjee; Jin Sheng-Chih; Kai Yu; Meredith Yeager; Constance Chen; Kevin Jacobs; William Wheeler; Maria Teresa Landi; Regina G Ziegler; David J Hunter; Stephen Chanock; Susan Hankinson; Peter Kraft; Andrew W Bergen
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

Review 10.  Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease.

Authors:  Letizia Polito; Antonio Greco; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.